Developing breakthrough oncology drug candidates

Sprint Bioscience is a pharmaceutical company focused on developing innovative drug candidates that can contribute to new treatments for cancer. The great need for new therapies for difficult-to-treat cancers has great commercial potential.

Using a fragment-based drug development approach, we develop drug programmes in a time- and resource-efficient manner that are out-licensed to global pharmaceutical companies during the preclinical phase.